ATXI
AVENUE THERAPEUTICS, INC.Company with tickers: ATXI
CIK
1644963
Shares Outstanding
3,294,635
Price
Holdings
Short Volume
Short Interest
Fails to Deliver
SEC Filings
Earnings Calls
Insider Trading
Congress Trades
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-01-02 | Fortress Biotech, Inc. | 10% Owner | Award | 111,209 |
| 2025-03-31 | Fortress Biotech, Inc. | 10% Owner | Award | 33,724 |
| 2024-12-31 | Fortress Biotech, Inc. | 10% Owner | Other | 294,800 |
| 2024-12-02 | Herskowitz Neil | Director | Sell | 23 |
| 2024-11-05 | KRANZLER JAY D | Director | Sell | 61 |
| 2024-09-30 | KRANZLER JAY D | Director | Buy | 497 |
| 2024-09-27 | KRANZLER JAY D | Director | Buy | 3 |
| 2024-09-23 | Herskowitz Neil | Director | Award | 30,000 |
| 2024-09-23 | Oltmans Curtis Gale | Director | Award | 30,000 |
| 2024-09-23 | KRANZLER JAY D | Director | Award | 30,000 |
| 2024-09-23 | ROSENWALD LINDSAY A MD | Director | Award | 30,000 |
| 2024-09-23 | MacLean Alexandra | Director, Chief Executive Officer | Award | 170,000 |
| 2024-09-23 | Jin David | Director | Award | 65,000 |
| 2024-09-23 | Charles Faith L. | Director | Award | 30,000 |
| 2024-04-16 | Fortress Biotech, Inc. | 10% Owner | Award | 413,507 |
| 2024-01-02 | Fortress Biotech, Inc. | 10% Owner | Award | 2,101,496 |
| 2023-12-11 | Davidow Robert L | 10% Owner | Sell | 264,000 |
| 2023-10-31 | Davidow Robert L | 10% Owner | Other | 945,000 |
| 2023-09-08 | ROSENWALD LINDSAY A MD | Director | Buy | 348,675 |
| 2023-09-08 | Fortress Biotech, Inc. | 10% Owner | Buy | 418,410 |
| 2023-06-30 | Herskowitz Neil | Director | Award | 100,000 |
| 2023-06-30 | Jin David | Director | Award | 250,000 |
| 2023-06-30 | KRANZLER JAY D | Director | Award | 100,000 |
| 2023-06-30 | Charles Faith L. | Director | Award | 100,000 |
| 2023-06-30 | ROSENWALD LINDSAY A MD | Director | Award | 100,000 |
| 2023-06-30 | Oltmans Curtis Gale | Director | Award | 100,000 |
| 2023-06-29 | MacLean Alexandra | Director, Chief Executive Officer | Award | 800,000 |
| 2023-03-31 | Fortress Biotech, Inc. | 10% Owner | Award | 52,419 |
| 2023-01-03 | Fortress Biotech, Inc. | 10% Owner | Award | 231,316 |
| 2022-12-31 | Fortress Biotech, Inc. | 10% Owner | Other | 250,000 |
| 2022-12-31 | Fortress Biotech, Inc. | 10% Owner | Award | 90,909 |
| 2022-10-11 | InvaGen Pharmaceuticals, Inc. | 10% Owner | Other | 0 |
| 2022-10-11 | InvaGen Pharmaceuticals, Inc. | 10% Owner | Sell | 388,888 |
| 2022-08-01 | MacLean Alexandra | Director, Chief Executive Officer | Other | 0 |
| 2022-05-16 | Charles Faith L. | Director | Other | 0 |
| 2022-05-11 | Jin David | Director | Other | 0 |
| 2021-12-17 | KRANZLER JAY D | Director | Award | 49,020 |
| 2021-12-17 | Herskowitz Neil | Director | Award | 49,020 |
| 2021-12-17 | Oltmans Curtis Gale | Director | Award | 49,020 |
| 2021-12-17 | Lu Lucy | Director, President, CEO | Award | 411,616 |
| 2021-12-17 | Vazzano Joseph Walter | Chief Financial Officer | Award | 100,505 |
| 2021-09-15 | Vazzano Joseph Walter | Chief Financial Officer | Sell | 7,160 |
| 2021-05-06 | Herskowitz Neil | Director | Buy | 2,500 |
| 2021-04-01 | Oltmans Curtis Gale | Director | Other | 0 |
| 2020-08-20 | Vazzano Joseph Walter | Chief Financial Officer | Sell | 3,840 |
| 2020-06-16 | Herskowitz Neil | Director | Award | 10,000 |
| 2020-06-16 | KRANZLER JAY D | Director | Award | 10,000 |
| 2020-03-10 | Vazzano Joseph Walter | Chief Financial Officer | Buy | 1,889 |
| 2020-03-09 | Vazzano Joseph Walter | Chief Financial Officer | Buy | 1,400 |
| 2020-02-27 | Herskowitz Neil | Director | Buy | 2,400 |
| 2020-02-26 | Herskowitz Neil | Director | Buy | 161 |
| 2020-02-25 | Vazzano Joseph Walter | Chief Financial Officer | Buy | 1,200 |
| 2020-02-25 | Herskowitz Neil | Director | Buy | 10,000 |
| 2020-02-12 | Lu Lucy | Director, President, CEO | Award | 110,959 |
| 2020-02-12 | Vazzano Joseph Walter | Chief Financial Officer | Award | 22,727 |